Kirsten Bibbins-Domingo

@[email protected]
13 Followers
40 Following
9 Posts
Editor in Chief, JAMA and the JAMA Network (jama.com)
Professor, University of California, San Francisco
scientist-physician-teacher
Views are my own
Kirsten Bibbins-DomingoOct 25, 2023

Neill Adhikari presenting his paper, simultaneously published in JAMA

Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized RCTs
https://jamanetwork.com/journals/jama/fullarticle/2811212

Accompanying editorial “the results…should lead clinicians to use therapies that have been demonstrated to be beneficial in patients with COVID-19 as opposed to one that is almost certainly ineffective & potentially harmful” https://jamanetwork.com/journals/jama/fullarticle/2811216

Intravenous Vitamin C for Patients Hospitalized With COVID-19

Two randomized clinical trials were harmonized to compare the effect of vitamin C vs control on outcomes in hospitalized patients with COVID-19 who were critically ill or who were not critically ill.

Kirsten Bibbins-DomingoOct 25, 2023

Hot Topics session always closes @ESICM -

Moderated by Derek Angus JAMA , Darren Taichman NEJM, & #ESICM President @ElieAzoulay5

#LIVES2023

Kirsten Bibbins-DomingoSep 21, 2023

What a pleasure to speak with Dr Michael Howell @mdhowellmd at #GoogleHealth - I learned quite a bit!

WATCH the video
LISTEN to the podcast, or
READ the Q & A https://jamanetwork.com/journals/jama/fullarticle/2809887

…& follow the JAMA “AI in Clinical Practice” series on our channel https://jamanetwork.com/channels/ai

Google Health’s Clinical Chief Talks AI in Health Care

This Medical News article is an interview with Michael Howell, MD, MPH, about applications of large language models in medicine.

Kirsten Bibbins-DomingoSep 16, 2023

Most viewed at JAMA in the last thirty days?

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial

https://jamanetwork.com/journals/jama/fullarticle/2808950?resultClick=1

Single-Dose Psilocybin Treatment for Major Depressive Disorder

This randomized clinical trial examines the timing of onset of action, durability of benefit, and safety profile of single-dose psilocybin in patients with major depressive disorder compared with placebo.

Kirsten Bibbins-DomingoSep 16, 2023

New in JAMA

Ulcerative Colitis in Adults:
A Review

by Drs Beatriz Gros & Gilaad Kaplan

https://jamanetwork.com/journals/jama/fullarticle/2809412

Ulcerative Colitis in Adults—A Review

This review discusses the epidemiology, pathophysiology, diagnosis, and treatment of ulcerative colitis in adults.

Kirsten Bibbins-DomingoSep 15, 2023

I’ve had the good fortune to speak with AI innovators & health care thought leaders on how this AI will transform the practice of medicine & the conduct of science.

I hope you will join us for these JAMA video and podcast conversations released on Wednesdays starting September 20th at https://jamanetwork.com/channels/ai

https://youtube.com/watch?v=wdRq_ZENMwY&si=3XraMbPpxEyHIesX

Artificial Intelligence (AI) Research and Opinion Articles from JAMA Network

Explore clinical applications of AI in the JAMA Network, including research and opinion about the use of deep learning and neural networks for clinical image analysis, natural language processing, EHR data mining, and more

Kirsten Bibbins-DomingoDec 26, 2022
Grateful to spend Christmas Eve with this crew! Merry Christmas to all celebrating today!
Kirsten Bibbins-DomingoDec 19, 2022
Last week we announce a new policy at JAMA and the JAMA Network that allows authors to deposit their accepted manuscript in a public repository of their choosing immediately upon publication. https://jamanetwork.com/journals/jama/fullarticle/2799743?guestAccessKey=5b96e9c2-007f-4503-bf3a-604785eb9b40&utm_source=twitter&utm_medium=social_jama&utm_term=8416047469&utm_campaign=article_alert&linkId=193649594
New JAMA Policy for Public Access to Scientific Research Findings and Principles of Biomedical Research

Timely access to scientific research findings for the broadest possible audience is a principle on which sound science is based. Access to new findings helps other scientists adjust their hypotheses and open new lines of inquiry, thereby supporting and accelerating further discovery and innovation....

Kirsten Bibbins-DomingoDec 19, 2022
Adrianna McIntyreDec 19, 2022

New working paper documents considerable mortality decreases among Black patients with chronic illnesses with racially concordant physicians: https://www.nber.org/papers/w30767

"We find striking evidence that racial concordance leads to improved maintenance of preventive care – and ultimately lower patient mortality... we estimate that a one-standard deviation increase in the share of providers who are Black leads to a 15% relative decline in Black mortality among those with these manageable illnesses."

Racial Concordance and the Quality of Medical Care: Evidence from the Military

Founded in 1920, the NBER is a private, non-profit, non-partisan organization dedicated to conducting economic research and to disseminating research findings among academics, public policy makers, and business professionals.

NBER